Injection treatment for thumb osteoarthritis
Official title: Randomized Placebo Controlled Study of Triamcinolone Acetonide Extended Release Injection for Thumb (CMC) Osteoarthritis
Run by Stony Brook University · NCT06237153 · Data updated 2026-11-12
This study is testing if a special steroid injection can help people with thumb arthritis feel less pain and use their thumbs better compared to a placebo injection.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Stony Brook University Academic / other |
| Locations | 1 site (Stony Brook, New York) |
| Status | Recruiting |
| Started | November 21, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | February 1, 2024 |
| Trial ID | NCT06237153 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 with a confirmed diagnosis of CMC osteoarthritis and a pain score of 5 or greater.
✕Probably not a fit
Patients with severe hypersensitivity to the treatment or those with certain medical conditions that compromise safety may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of a timed release steroid injection, Triamcinolone Acetonide extended release (TA-ER), in treating carpometacarpal (CMC) joint osteoarthritis in the thumb. Participants will receive either the TA-ER injection or a placebo saline injection, followed by assessments of pain and thumb function over a 12-week period. The goal is to determine if the steroid injection can significantly reduce pain and improve thumb functionality compared to the placebo. This approach aims to provide a safer and longer-lasting conservative treatment option for patients suffering from CMC osteoarthritis.
Why it matters
Potential benefit: If successful, this treatment could provide significant pain relief and improved thumb function for patients with CMC osteoarthritis.
How similar studies have gone: While this approach is novel for CMC osteoarthritis, similar steroid injection methods have shown success in treating other types of osteoarthritis.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female \> 18 years of age. 2. X ray diagnosis of CMC osteoarthritis Eaton stages I, II or III. 3. VAS pain score in affected thumb of 5 or greater. 4. Written informed consent obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study. 5. Willing to abstain from use of the following protocol-restricted medications during the study to be kept in a log if non compliant. * Opioid or over the counter medications for pain for the study duration Exclusion Criteria: 1. Females who are pregnant or nursing or plan to become pregnant during the study; women who plan to conceive during the study; or unwilling to practice birth control during participation in the study. 2. Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data. 3. Known or suspected hypersensitivity to TA-ER (or component of TA-ER), triamcinolone acetonide. 4. Stage IV CMC osteoarthritis is excluded. Rationale for exclusion of stage IV is that these patients are most likely surgical candidates due to severe joint damage. Other exclusion criteria include rheumatoid arthritis, septic or gouty arthritis or psoriatic arthritis, thumb joint effusion, DeQuervain's disease, trigger thumb or history of CMC joint surgical reconstruction, or terminal or chronic and serious, uncontrolled associated medical conditions. Patients who have received hyaluronan or platelet rich plasma (PRP) injections to the affected CMC joint within 6 months will be excluded. Patients who have received a steroid injection to the affected CMC joint within 3 months will be excluded.
Where it's running
-
Stony Brook Orthopaedics
Stony Brook, New York, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Short-Term Low-Protein Diet Around Chemotherapy for ER+/HER2- Breast Cancer
A short-term, reduced-protein diet is being tested around the first four cycles of neoadjuvant chemotherapy to see if patients can follow it and stay adherent.
-
HemoPill Acute to Detect Blood in Upper GI Tract Before Endoscopy
This study tests whether the HemoPill acute can detect blood in patients suspected of upper GI bleeding before they undergo endoscopy.
-
Behavioral Activation for Depression in Autistic Teens with Below-Average IQ
This study tests a tailored behavioral activation approach to see if it helps reduce depressive symptoms in autistic adolescents who have below-average cognitive abilities.
-
Hydrogen water for ME/CFS: a 16-week comparison to placebo
This 16-week pilot study tests whether hydrogen water helps reduce fatigue and improve physical function in adults with ME/CFS, compared with a placebo.
-
Dual-Site Ear Nerve Stimulation for Severe Brain Injury-Related Coma
This study tests a gentle, non-invasive stimulation on the left ear to try to help some people in coma due to severe traumatic brain injury regain awareness.
-
Postpartum Mom Power for Opioid Use Disorder
This study tests a Mother Power parenting program in moms with opioid use disorder to see if it helps reduce cravings, stress, and improve brain responses to infant cues compared with enhanced usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.